Treatment pattern of early-stage premenopausal breast cancer patients with low Oncotype DX score: Single center experience

被引：0
|
作者：
Al Saheli, Zaid Ihab
Ammari, Omar
Albusoul, Linda
Dabak, Vrushali S.
机构：
[1] Henry Ford Hlth Syst, Dept Hematol Oncol, Detroit, MI USA
[2] Henry Ford Hosp, Detroit, MI 48202 USA
[3] Henry Ford Hlth, Henry Ford Canc Inst, Detroit, MI USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e12510
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Clinical outcomes and Oncotype DX Breast Recurrence Score (R) in early-stage BRCA-associated hormone receptor-positive breast cancer
    Layman, Rachel M.
    Lin, Heather
    Barrera, Angelica M. Gutierrez
    Karuturi, Meghan S.
    Yam, Clinton
    Arun, Banu K.
    CANCER MEDICINE, 2022, 11 (06): : 1474 - 1483
  • [42] Cost Effectiveness of the Oncotype DX Genomic Prostate Score for Guiding Treatment Decisions in Patients With Early Stage Prostate Cancer
    Chang, Eric M.
    Punglia, Rinaa S.
    Steinberg, Michael L.
    Raldow, Ann C.
    UROLOGY, 2019, 126 : 89 - 95
  • [43] Correlation between Oncotype Dx score with histologic grade, tumor size and Ki67 in patients with early stage breast cancer: A single academic institution experience.
    Lathrop, Kate Ida
    Mazo-Canola, Marcela
    Gelfond, Jonathan
    Hinojosa, Barbara
    Shiao, Jay C.
    Terracina, Katherine A.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (28)
  • [44] Correlation between Oncotype DX score with histologic grade, tumor size and Ki67 in patients with early stage breast cancer: A single academic institution experience.
    Lathrop, Kate Ida
    Mazo-Canola, Marcela
    Gelfond, Jonathan
    Shiao, Jay C.
    Hinojosa, Barbara
    Terracina, Katherine A.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [45] Factors influencing Oncotype DX use in the management of early breast cancer: A single centre experience
    Zhu, Xiaofu
    Dent, Susan
    Paquet, Lise
    Zhang, Tinghua
    Graham, Nadine
    Song, Xinni
    EUROPEAN JOURNAL OF CANCER, 2014, 50 (15) : 2544 - 2549
  • [46] The relationship of oncotype Dx Recurrence Score (RS) with Ki 67 in early stage breast cancer patients in a community based cancer center in rural central Nebraska.
    Copur, Mehmet Sitki
    Peterson, Tonya
    Tun, Soe Min
    Horn, Adam
    Wedel, Whitney
    Duckert, Randall
    Lintel, Nicholas
    Springer, Carlene R.
    Muske, Chandra
    Robbins, Leslie
    Arbogast, Jessica
    Fakkema, Emily
    Marshall, Alison
    Brunt, Kathryn
    Kelly, Jacqueline
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [47] Understanding Ethnoracial Differences in Oncotype DX Recurrence Scores in Patients with Early-Stage Breast Cancer: An Analysis Based on Hispanic Ethnicity
    Bazan, Jose G.
    Jhawar, Sachin R.
    Stover, Daniel
    Beyer, Sasha
    White, Julia
    Obeng-Gyasi, Samilia
    CANCER RESEARCH, 2023, 83 (05)
  • [48] The impact of delayed implementation of the Oncotype DX® test on patient health outcomes and societal costs for early-stage breast cancer patients
    Levin, L. -A
    Appelberg, K.
    BREAST, 2025, 80
  • [49] A comparative analysis of distant recurrence risk assessments by Oncotype DX recurrence score alone and integrated with clinicopathologie factors in early-stage breast cancer
    Kelly, Clara Marie
    Beamish, Rose
    McCaffrey, John
    Smith, Martina
    Crown, John
    O'Connor, Miriam
    McGee, Sharon F.
    O'Reilly, Seamus
    Moylan, Eugene J.
    Gonzalez-Angulo, Ana M.
    Litton, Jennifer Keating
    Pusztal, Lajos
    Kelly, Catherine Margaret
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [50] Evaluation Oncotype DX® 21-Gene Recurrence Score and clinicopathological parameters in early stage breast cancer
    Lashen, A. L.
    Toss, M. T.
    Fadhil, W. F.
    Oni, G. O.
    Madhusudan, S. M.
    Rakha, E. R.
    JOURNAL OF PATHOLOGY, 2023, 261 : S10 - S10
12345